Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. MDS - Basics

    ... are more severe, and carry a high risk of becoming acute myelogenous leukemia (AML). The subtype you have, and the severity of your ...

    Topic section last updated 06/12/2018 - 12:47pm.

  2. Repurposing older drugs to help prevent GVHD

    ... (vorinostat) is safe and results in low incidence of acute graft-versus-host disease (GVHD) after reduced-intensity ... age was 56 years (range, 18-69 years), and 95% had acute myelogenous leukemia or high-risk myelodysplastic syndrome. Vorinostat was ...

    Article last updated 10/18/2017 - 8:48am.

  3. Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

    ... high risk myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are commonly older with multiple co-morbidities, ...

    Research Article last updated 05/22/2017 - 11:42am.

  4. Treatments

    ... risk IPSS score, you have a higher risk of developing Acute Myelogenous Leukemia (AML). To prevent this from happening, your doctor may ...

    Topic section last updated 08/07/2018 - 2:28pm.

  5. Drug reduces acute GVHD in unrelated HSCTs

    ... Article Link:  Vorinostat Lowers Acute GVHD in Patients Receiving Unrelated Donor HSCT ... not an easy population. Most of our patients had acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS), and these are ...

    Article last updated 02/27/2017 - 1:45pm.

  6. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016

    ... blood cytopenias and, sometimes, progression to acute myelogenous leukemia . Research efforts have been made all over the world to ...

    Research Article last updated 01/24/2017 - 11:54am.

  7. Molecular Testing in Patients with Suspected Myelodysplastic Syndromes

    ... and with a propensity to transform to acute myelogenous leukemia . Newer technologies such as next-generation sequencing have ...

    Research Article last updated 11/02/2016 - 10:09am.

  8. Top expert calls future MDS/AML care “promising”

    ... paradigms for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), researchers predict that hypomethylating agents, ... diseases—myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). I focused more on MDS because it’s my primary ...

    Article last updated 11/02/2016 - 11:28am.

  9. AAMDSIF partners on new MDS patient resource

    ... Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Acute Lymphocytic Leukemia (ALL); Caring for Adolescents and Young Adults; Chronic Lymphocytic Leukemia (CLL); Chronic Myelogenous Leukemia (CML); Hodgkin Lymphoma; Lung Cancer Screening; Malignant ...

    Article last updated 06/28/2016 - 12:43pm.

  10. Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

    ... orally, twice daily for 21-day cycles, in patients with Acute Myelogenous Leukemia (AML) orMyelodysplastic Syndrome (MDS). ...

    Clinical Trial last updated 04/27/2016 - 3:39pm.